A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Al-Abdullah, Ismail, Ph.D. Bookmark and Share

Ismail Al-Abdullah, Ph.D. Research

Coating Human Islets with Macromolecular Heparin
This project is carried out in collaboration with University of Uppsala Sweden.  Achieving successful reversal of diabetes with minimum Heparin precoated islet mass would have a major impact in translating the result generated from this study to clinical practice to use islet isolated from a single donor to reverse a single type 1 diabetic recipient.
 
Growth Factors in Culture Media Supplement to Improve Islet Quality and Quantity
This proposal will test the hypothesis that culturing islets in serum free medium supplemented with growth factors such as gastrin, EGF and exendin can promote islet function, yields; promote proliferation of islet progenitor cells to ultimate transplantation of islets from a single donor.

The Role of alpha-glutathione S-transferase (α-GST) in Human Islets
The ultimate goal of this study is to develop a simple, fast and reliable biomarker to monitor islet function and survival. Based on our feasibility study that islets are indeed contain and secrete α-GST. This novel biomarker will be used to monitor islet function during the isolation and post culture. We intend to use this biomarker to monitor islet integrity and develop the best conditions for islet recovery and survival post transplant.
 
Collaboration with the University of Uppsala
Our main focus on this collaboration is to further improve our islet isolation procedure for enhancing and improving islet quality so that a single diabetic patient could be transplanted and reverse diabetes with islets isolated from a single donor.
 
Collaboration on Non-Human Primate Islet Transplantation Protocol
We have initiated this collaboration with Dr. Defu Zeng and University of Maryland for induction of tolerance in the recipients. Donor pancreas from non-human primate was shipped and the isolated islets when transplanted into diabetic mice, diabetes were reversed.  The outcome of this study results obtain from this study will have major impact for FDA approval for eventual application of novel strategies for tolerance induction to cure type 1 diabetic patients with islets isolated from cadaveric donors.
 
Development of Novel Peptide for Collagenase and Neutral Protease Activities
Collaboration with Dr. Markus Kalkum from the immunology department at City of Hope has been established and we have already developed a novel peptide for collagenase and neutral protease activities assessment to define a better enzymes for pancreas digestion to free the islets for ultimate goal to transplant islets into a single diabetic recipient isolated from a single cadaveric donor pancreas.
 

Ismail Al-Abdullah, Ph.D. Lab Members

Ismail Al-Abdullah, Ph.D.
Research Professor
626-246-HOPE (4673) ext. 60109
 
Luis Valiente
Senior Research Associate
626-246-HOPE (4673) ext. 65639
 
Shiela Bilbao
Research Associate II
626-246-HOPE (4673) ext. 61410
 
Alina Oancea, M.D.
Research Associate II
626-246-HOPE (4673) ext. 63923
 
Brian McFadden
626-246-HOPE (4673) ext. 33101
Research Associate I
 

Al-Abdullah, Ismail, Ph.D.

Ismail Al-Abdullah, Ph.D. Research

Coating Human Islets with Macromolecular Heparin
This project is carried out in collaboration with University of Uppsala Sweden.  Achieving successful reversal of diabetes with minimum Heparin precoated islet mass would have a major impact in translating the result generated from this study to clinical practice to use islet isolated from a single donor to reverse a single type 1 diabetic recipient.
 
Growth Factors in Culture Media Supplement to Improve Islet Quality and Quantity
This proposal will test the hypothesis that culturing islets in serum free medium supplemented with growth factors such as gastrin, EGF and exendin can promote islet function, yields; promote proliferation of islet progenitor cells to ultimate transplantation of islets from a single donor.

The Role of alpha-glutathione S-transferase (α-GST) in Human Islets
The ultimate goal of this study is to develop a simple, fast and reliable biomarker to monitor islet function and survival. Based on our feasibility study that islets are indeed contain and secrete α-GST. This novel biomarker will be used to monitor islet function during the isolation and post culture. We intend to use this biomarker to monitor islet integrity and develop the best conditions for islet recovery and survival post transplant.
 
Collaboration with the University of Uppsala
Our main focus on this collaboration is to further improve our islet isolation procedure for enhancing and improving islet quality so that a single diabetic patient could be transplanted and reverse diabetes with islets isolated from a single donor.
 
Collaboration on Non-Human Primate Islet Transplantation Protocol
We have initiated this collaboration with Dr. Defu Zeng and University of Maryland for induction of tolerance in the recipients. Donor pancreas from non-human primate was shipped and the isolated islets when transplanted into diabetic mice, diabetes were reversed.  The outcome of this study results obtain from this study will have major impact for FDA approval for eventual application of novel strategies for tolerance induction to cure type 1 diabetic patients with islets isolated from cadaveric donors.
 
Development of Novel Peptide for Collagenase and Neutral Protease Activities
Collaboration with Dr. Markus Kalkum from the immunology department at City of Hope has been established and we have already developed a novel peptide for collagenase and neutral protease activities assessment to define a better enzymes for pancreas digestion to free the islets for ultimate goal to transplant islets into a single diabetic recipient isolated from a single cadaveric donor pancreas.
 

Lab Members

Ismail Al-Abdullah, Ph.D. Lab Members

Ismail Al-Abdullah, Ph.D.
Research Professor
626-246-HOPE (4673) ext. 60109
 
Luis Valiente
Senior Research Associate
626-246-HOPE (4673) ext. 65639
 
Shiela Bilbao
Research Associate II
626-246-HOPE (4673) ext. 61410
 
Alina Oancea, M.D.
Research Associate II
626-246-HOPE (4673) ext. 63923
 
Brian McFadden
626-246-HOPE (4673) ext. 33101
Research Associate I
 
City of Hope combines compassionate care with the best and most innovative science. Our 100+ acre campus is designed to meet the full range of needs of our patients and families. This guide is designed to help you take advantage of all that is offered at City of Hope - Duarte.
To make an appointment for yourself, a family member or a friend, please complete and submit our Become a Patient Request Form, or call City of Hope at
800-826-HOPE (4673).
Contact Us
Phone: (800) 826-HOPE (4673)
 
Hours: M – F, 8 a.m. to 5 p.m. (PST)
 
Calls received after 5 p.m. will be returned the next business day.
Patient Care Overview

The Sheri & Les Biller Patient and Family Resource Center embodies the heart and soul of City of Hope’s mission to care for the whole person.
Info for Referring Physicians
City of hope welcomes patient referrals from physicians throughout the world. City of Hope is located near northeast Los Angeles, in Duarte, California.

NEWS & UPDATES
  • Advanced age tops the list among breast cancer risk factor for women. Not far behind is family history and genetics. Two City of Hope researchers delving deep into these issues recently received important grants to advance their studies. Arti Hurria, M.D., director of the Cancer and Aging Research Program, and ...
  • City of Hope is extending the reach of its lifesaving mission well beyond U.S. borders. To that end, three distinguished City of Hope leaders visited China earlier this year to lay the foundation for the institution’s new International Medicine Program. The program is part of City of Hope’s strategi...
  • A hallmark of cancer is that it doesn’t always limit itself to a primary location. It spreads. Breast cancer and lung cancer in particular are prone to spread, or metastasize, to the brain. Often the brain metastasis isn’t discovered until years after the initial diagnosis, just when patients were beginning to ...
  • Blueberries, cinnamon, baikal scullcap, grape seed extract (and grape skin extract), mushrooms, barberry, pomegranates … all contain compounds with the potential to treat, or prevent, cancer. Scientists at City of Hope have found tantalizing evidence of this potential and are determined to explore it to t...
  • Most women who are treated for breast cancer with a mastectomy do not choose to undergo reconstructive surgery. The reasons for this, according to a recent JAMA Surgery study, vary. Nearly half say they do not want any additional surgery, while nearly 34 percent say breast cancer reconstruction simply isn’t imp...
  • The leading risk factor for breast cancer is simply being a woman. The second top risk factor is getting older. Obviously, these two factors cannot be controlled, which is why all women should be aware of their risk and how to minimize those risks. Many risk factors can be mitigated, and simple changes can lead...
  • All women are at some risk of developing the disease in their lifetimes, but breast cancer, like other cancers, has a disproportionate effect on minorities. Although white women have the highest incidence of breast cancer, African-American women have the highest breast cancer death rates of all racial and ethni...
  • First, the good news: HIV infections have dropped dramatically over the past 30 years. Doctors, researchers and health officials have made great strides in preventing and treating the disease, turning what was once a death sentence into, for some, a chronic condition. Now, the reality check: HIV is still a worl...
  • Screening for breast cancer has dramatically increased the number of cancers found before they cause symptoms – catching the disease when it is most treatable and curable. Mammograms, however, are not infallible. It’s important to conduct self-exams, and know the signs and symptoms that should be checked by a h...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free.   In his previ...
  • In a single day, former professional triathlete Lisa Birk learned she couldn’t have children and that she had breast cancer. “Where do you go from there?” she asks. For Birk, who swims three miles, runs 10 miles and cycles every day, the answer  ultimately was a decision to take control of her cancer care. Afte...
  • More and more people are surviving cancer, thanks to advanced cancer treatments and screening tools. Today there are nearly 14.5 million cancer survivors in the United States. But in up to 20 percent of cancer patients, the disease ultimately spreads to their brain. Each year, nearly 170,000 new cases of brain ...
  • Cancer cells are masters of survival. Despite excessive damage to their most basic workings and the constant vigilance of the body’s immune system, they manage to persevere. Much of this extraordinary ability to survive falls under the control of proteins bearing the name STAT, short for signal transducer and a...
  • One person receives the breast cancer diagnosis, but the cancer affects the entire family. Couples, in particular, can find the diagnosis and treatment challenging, especially if they have traditional male/female communication styles. “Though every individual is unique, men and women often respond differently d...
  • Here’s a statistic you’ll hear and read frequently over the next month: One in eight women born in the United States will develop breast cancer at some point in her lifetime. Although this statement is accurate, based on breast cancer incidence rates in 2013, it’s often misunderstood. Leslie Bernstein, Ph.D., d...